Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Cash & Equivalents (2016 - 2025)

Hypha Labs (FUNI) has disclosed Cash & Equivalents for 15 consecutive years, with $147192.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash & Equivalents fell 71.08% year-over-year to $147192.0, compared with a TTM value of $147192.0 through Jun 2025, down 71.08%, and an annual FY2024 reading of $91166.0, down 66.36% over the prior year.
  • Cash & Equivalents was $147192.0 for Q2 2025 at Hypha Labs, up from $21093.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.1 million in Q1 2024 and bottomed at $21093.0 in Q1 2025.
  • Average Cash & Equivalents over 5 years is $221218.2, with a median of $131530.0 recorded in 2023.
  • The sharpest move saw Cash & Equivalents skyrocketed 817.77% in 2024, then tumbled 98.02% in 2025.
  • Year by year, Cash & Equivalents stood at $90305.0 in 2021, then soared by 72.56% to $155832.0 in 2022, then surged by 97.81% to $308252.0 in 2023, then crashed by 88.13% to $36583.0 in 2024, then soared by 302.35% to $147192.0 in 2025.
  • Business Quant data shows Cash & Equivalents for FUNI at $147192.0 in Q2 2025, $21093.0 in Q1 2025, and $36583.0 in Q4 2024.